Drugs Made In America Acquisition II (DMIIR) Stock Insights
DMIIR$0.06-0.01 -15.71%
$3.76M
Market Cap
—
P/E
—
Forward P/E
—
Score
Drugs Made In America Acquisition II (DMIIR) Stock Insights
DMIIR price $0.06 -0.01 -15.71%
- Ticker
- DMIIR
- Price
- $0.06
- Change
- -0.01 -15.71%
- Market cap ?
- $3.76M
- Beta ?
- 2.05
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
Fair value
DMIIR fair value $2.86. Price $0.06. Price is 98% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| No data yet. | ||||
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| No data yet. | |||||
Institutional holders
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Insights · Dividends · Forecast · Financials · Learn